• ab medica
  • Allium
  • Bard
  • BK Ultrasound
  • Coloplast
  • Elesta
  • Koelis
  • Lamidey
  • Lumenis
  • Malem
  • Medi Tate
  • ModìLite
  • Paramount Medical Solutions
  • Pusen
  • Quanta System
  • Rocamed
  • SoracteLite
  • Wellead

Prostatic Biopsy System 3D Fusion

  • cancer-managment.png

  • prostata-1.png

Koelis is a young and innovative company, specialized in computer-assisted Urology. He is part of a French industrial and scientific advanced surgery consortium, whose philosophy is to encourage clinical innovation by providing high-tech medical devices for image-based or robotic surgical assistance.
UROSTATION implements the ProMap software application. Based on five years of research in image processing and recording techniques, it has been certified in many countries and has benefited more than 10,000 patients so far. The software allows visual planning in real time, guidance and registration of the 3D mapping of prostatic biopsy. ProMap implements a revolutionary process that allows accurate prostate monitoring despite probe-induced mobility. In this way, guided operation, recording and analysis of the areas reached and, consequently, the choice of treatment and planning becomes possible.
UROSTATION receives DICOM images from a compatible 3D ultrasound that guides a 3D end-fire endocavity probe. The doctor usually finds the orientation of the probe and its needle using 2D ultrasounds and at any time can check the position of the part that interests him simply by pressing freeze. The 3D cartography of the biopsies is constructed step by step and is shown on a reference image of the 3D TRUS prostate (Trans Rectal Prostatic Ultrasound). An illustrated operational report is available upon completion of the intervention.
An advanced version of the PROMAP-MR software makes it possible to fuse images of Magnetic Resonance with 3D-mapped biopsy in order to target and localize biopsies with regard to suspicious areas of magnetic resonance.
An advanced version of the PROMAP-2L software makes it possible to merge magnetic resonance images with 3D-mapped biopsy in order to target and localize biopsies with regard to suspicious areas of magnetic resonance.